Why the study?
Does taurine supplementation improve clinical outcomes in cats with dilated cardiomyopathy and low plasma taurine concentrations?
Population
156 cats, comprising 79 healthy cats and 77 cats with dilated cardiomyopathy (DCM)
Design
Preclinical
Follow-up
up to 4 to 8 weeks
Authors
Loading...
Hypothesis-generating for taurine supplementation in feline DCM; prospective trials needed before clinical adoption.
Does taurine supplementation improve clinical outcomes in cats with dilated cardiomyopathy and low plasma taurine concentrations?
Low plasma taurine concentrations are highly prevalent in cats with dilated cardiomyopathy, and taurine supplementation can lead to clinical improvement in a subset of these animals.
Sisson et al. (1991) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: